Cargando…
Suppression of hepatic dysfunction in tenascin-X-deficient mice fed a high-fat diet
Extracellular matrix glycoprotein tenascin-X (TNX) is the largest member of the tenascin family. In the present study, the contribution of TNX to liver dysfunction was investigated by administration of high-fat and high-cholesterol diet with high levels of phosphorus and calcium (HFCD) to wild-type...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646988/ https://www.ncbi.nlm.nih.gov/pubmed/28731143 http://dx.doi.org/10.3892/mmr.2017.7052 |
_version_ | 1783272181639151616 |
---|---|
author | Yamaguchi, Shinsaku Kawakami, Kohei Satoh, Kazumi Fukunaga, Naoki Akama, Kazuhito Matsumoto, Ken-Ichi |
author_facet | Yamaguchi, Shinsaku Kawakami, Kohei Satoh, Kazumi Fukunaga, Naoki Akama, Kazuhito Matsumoto, Ken-Ichi |
author_sort | Yamaguchi, Shinsaku |
collection | PubMed |
description | Extracellular matrix glycoprotein tenascin-X (TNX) is the largest member of the tenascin family. In the present study, the contribution of TNX to liver dysfunction was investigated by administration of high-fat and high-cholesterol diet with high levels of phosphorus and calcium (HFCD) to wild-type (WT) and TNX-knockout (KO) mice. After 16 weeks of HFCD administration, the ratio of liver weight to body weight was approximately 22% higher in the HFCD-fed WT mice compared with the HFCD-fed TNX-KO mice, indicating hepatomegaly in HFCD-fed WT mice. Histological analyses with hematoxylin and eosin staining at 21 weeks revealed that hepatocyte hypertrophy in HFCD-fed TNX-KO mice was suppressed to 85% of that in HFCD-fed WT mice. By contrast, there was a 1.2-fold increase in lipid deposition in hepatocytes from HFCD-fed TNX-KO mice compared with HFCD-fed WT mice at 18 weeks, as demonstrated by Oil Red O staining. In addition, TNX-KO mice at 21 weeks and 27 weeks post-HFCD administration exhibited significant suppression of inflammatory cell infiltrate to 51 and 24% of that in WT mice, respectively. Immunofluorescence analysis for type I collagen and Elastica van Gieson staining demonstrated a clear hepatic fibrosis progression in HFCD-fed WT mice at 27 weeks, whereas hepatic fibrosis was undetected in HFCD-fed TNX-KO mice. The present findings indicated that TNX deficiency suppressed hepatic dysfunction induced by HFCD administration. |
format | Online Article Text |
id | pubmed-5646988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-56469882017-10-24 Suppression of hepatic dysfunction in tenascin-X-deficient mice fed a high-fat diet Yamaguchi, Shinsaku Kawakami, Kohei Satoh, Kazumi Fukunaga, Naoki Akama, Kazuhito Matsumoto, Ken-Ichi Mol Med Rep Articles Extracellular matrix glycoprotein tenascin-X (TNX) is the largest member of the tenascin family. In the present study, the contribution of TNX to liver dysfunction was investigated by administration of high-fat and high-cholesterol diet with high levels of phosphorus and calcium (HFCD) to wild-type (WT) and TNX-knockout (KO) mice. After 16 weeks of HFCD administration, the ratio of liver weight to body weight was approximately 22% higher in the HFCD-fed WT mice compared with the HFCD-fed TNX-KO mice, indicating hepatomegaly in HFCD-fed WT mice. Histological analyses with hematoxylin and eosin staining at 21 weeks revealed that hepatocyte hypertrophy in HFCD-fed TNX-KO mice was suppressed to 85% of that in HFCD-fed WT mice. By contrast, there was a 1.2-fold increase in lipid deposition in hepatocytes from HFCD-fed TNX-KO mice compared with HFCD-fed WT mice at 18 weeks, as demonstrated by Oil Red O staining. In addition, TNX-KO mice at 21 weeks and 27 weeks post-HFCD administration exhibited significant suppression of inflammatory cell infiltrate to 51 and 24% of that in WT mice, respectively. Immunofluorescence analysis for type I collagen and Elastica van Gieson staining demonstrated a clear hepatic fibrosis progression in HFCD-fed WT mice at 27 weeks, whereas hepatic fibrosis was undetected in HFCD-fed TNX-KO mice. The present findings indicated that TNX deficiency suppressed hepatic dysfunction induced by HFCD administration. D.A. Spandidos 2017-10 2017-07-21 /pmc/articles/PMC5646988/ /pubmed/28731143 http://dx.doi.org/10.3892/mmr.2017.7052 Text en Copyright: © Yamaguchi et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Yamaguchi, Shinsaku Kawakami, Kohei Satoh, Kazumi Fukunaga, Naoki Akama, Kazuhito Matsumoto, Ken-Ichi Suppression of hepatic dysfunction in tenascin-X-deficient mice fed a high-fat diet |
title | Suppression of hepatic dysfunction in tenascin-X-deficient mice fed a high-fat diet |
title_full | Suppression of hepatic dysfunction in tenascin-X-deficient mice fed a high-fat diet |
title_fullStr | Suppression of hepatic dysfunction in tenascin-X-deficient mice fed a high-fat diet |
title_full_unstemmed | Suppression of hepatic dysfunction in tenascin-X-deficient mice fed a high-fat diet |
title_short | Suppression of hepatic dysfunction in tenascin-X-deficient mice fed a high-fat diet |
title_sort | suppression of hepatic dysfunction in tenascin-x-deficient mice fed a high-fat diet |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646988/ https://www.ncbi.nlm.nih.gov/pubmed/28731143 http://dx.doi.org/10.3892/mmr.2017.7052 |
work_keys_str_mv | AT yamaguchishinsaku suppressionofhepaticdysfunctionintenascinxdeficientmicefedahighfatdiet AT kawakamikohei suppressionofhepaticdysfunctionintenascinxdeficientmicefedahighfatdiet AT satohkazumi suppressionofhepaticdysfunctionintenascinxdeficientmicefedahighfatdiet AT fukunaganaoki suppressionofhepaticdysfunctionintenascinxdeficientmicefedahighfatdiet AT akamakazuhito suppressionofhepaticdysfunctionintenascinxdeficientmicefedahighfatdiet AT matsumotokenichi suppressionofhepaticdysfunctionintenascinxdeficientmicefedahighfatdiet |